AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Extracorporeal Membrane Oxygenation Machines Market by Modality & Geography - Forecast and Analysis 2020-2024 - ResearchAndMarkets.com

January 16, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 16, 2020--

The “Extracorporeal Membrane Oxygenation Machines Market by Modality and Geography - Forecast and Analysis 2020-2024” report has been added to ResearchAndMarkets.com’s offering.

Global Extracorporeal Membrane Oxygenation Machines Market: About this market

The extracorporeal membrane oxygenation machines market analysis considers sales from veno-venous and arterio-venous; and veno-arterial modalities. Our study also finds the sales of extracorporeal membrane oxygenation machines in Asia, Europe, North America, and ROW. In 2019, the veno-venous and arterio-venous segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing cases of lung transplants will play a significant role in the veno-venous and arterio-venous segment to maintain its market position. Also, our global extracorporeal membrane oxygenation machines market report looks at factors such as increasing incidence of respiratory and heart failure, rising number of new product launches, and growing number of transplant procedures. However, high costs associated with cardiac and respiratory procedures, complications related to ECMO procedures, and frequent product recalls may hamper the growth of the extracorporeal membrane oxygenation machines industry over the forecast period.

Global Extracorporeal Membrane Oxygenation Machines Market: Overview

Increasing prevalence of respiratory and heart failure

Respiratory diseases such as COPD, ARDS, and pulmonary embolism affect a large number of people across the world every year. The rising prevalence of these diseases can be attributed to factors such as respiratory infections, smoking, and air pollution. Similarly, the prevalence of CVDs and other heart diseases such as ischemic heart disease, coronary heart disease, and myocardial infarctions has significantly increased over recent years. These factors have increased the number of emergency department visits, which has necessitated the need for immediate treatment. Extracorporeal membrane oxygenation machines are majorly used for reducing the chances of cardiac failure in people with CVDs. They are also used by healthcare professionals to help patients at the risk of sudden respiratory failure. Therefore, the increasing incidences of respiratory and heart failures will lead to the expansion of the global extracorporeal membrane oxygenation machines market at a CAGR of almost 5% during the forecast period.

Technological advances

The growing number of technological innovations has enabled a paradigm shift in the cost as well as the manageability of medical equipment. The launch of wearable devices has made patient monitoring much simpler and more cost-effective and has contributed to better patient adherence to health monitoring. Extracorporeal membrane oxygenation machines are majorly used in hospitals, clinics, and ASCs as a life-support device. They are majorly used by healthcare professionals during certain medical emergencies and surgical procedures. Technologically advanced and innovative devices are majorly used by clinicians for patients suffering from certain chronic conditions where support for the heart and lung is required. This development is expected to have a positive impact on the overall market growth.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: CUSTOMER LANDSCAPE

PART 07: GEOGRAPHIC LANDSCAPE

PART 08: MARKET SEGMENTATION BY MODALITY

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

For more information about this report visit https://www.researchandmarkets.com/r/86ip9j

View source version on businesswire.com:https://www.businesswire.com/news/home/20200116005399/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES CARDIOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/16/2020 07:12 AM/DISC: 01/16/2020 07:12 AM

http://www.businesswire.com/news/home/20200116005399/en